Finance

Lists
RHHVF:OTCMKTS
Roche Holding AG Genussscheine
430,32 US$
-0,88%
(-3,82) 1D
12 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RHHVF...
Open
430,06 US$
High
433,39 US$
Low
429,36 US$
Mkt. cap
349,46 მლრ.
Avg. vol.
4,73 ათ.
Volume
113,00
52-wk high
490,33 US$
52-wk low
318,81 US$
Beta
0,51
Shares outstanding
702,56 მლნ.
No. of employees
113 ათ.
Open
430,06 US$
High
433,39 US$
Low
429,36 US$
Mkt. cap
349,46 მლრ.
Avg. vol.
4,73 ათ.
Volume
113,00
52-wk high
490,33 US$
52-wk low
318,81 US$
Beta
0,51
Shares outstanding
702,56 მლნ.
No. of employees
113 ათ.
News stories
From web sources and news partners
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in the Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOთომას შინეკერი
Employees113 ათ.
Founded1 ოქტ. 1896
Headquartersბაზელი, ბაზელ-შტადტის კანტონი, შვეიცარია
SectorPharmaceutical industry
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
15,75 მლრდ.
15,75 მლრდ.
15,73 მლრდ.
15,73 მლრდ.
Cost of goods sold
4,21 მლრდ.
4,21 მლრდ.
3,93 მლრდ.
3,93 მლრდ.
Cost of revenue
4,21 მლრდ.
4,21 მლრდ.
3,93 მლრდ.
3,93 მლრდ.
Research and development expenses
3,15 მლრდ.
3,15 მლრდ.
2,99 მლრდ.
2,99 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,59 მლრდ.
3,59 მლრდ.
3,22 მლრდ.
3,22 მლრდ.
Operating expense
6,82 მლრდ.
6,82 მლრდ.
6,11 მლრდ.
6,11 მლრდ.
Total operating expenses
11,03 მლრდ.
11,03 მლრდ.
10,03 მლრდ.
10,03 მლრდ.
Operating income
4,72 მლრდ.
4,72 მლრდ.
5,69 მლრდ.
5,69 მლრდ.
Other non operating income
-10,00 მლნ.
-10,00 მლნ.
-15,00 მლნ.
-15,00 მლნ.
EBT including unusual items
3,69 მლრდ.
3,69 მლრდ.
4,49 მლრდ.
4,49 მლრდ.
EBT excluding unusual items
4,37 მლრდ.
4,37 მლრდ.
5,38 მლრდ.
5,38 მლრდ.
Income tax expense
709,00 მლნ.
709,00 მლნ.
824,00 მლნ.
824,00 მლნ.
Effective tax rate
19,20%
19,20%
18,37%
18,37%
Other operating expenses
77,50 მლნ.
77,50 მლნ.
-99,00 მლნ.
-99,00 მლნ.
Net income
2,74 მლრდ.
2,74 მლრდ.
3,44 მლრდ.
3,44 მლრდ.
Net profit margin
17,36%
17,36%
21,85%
21,85%
Earnings per share
-
-
-
-
Interest and investment income
45,00 მლნ.
45,00 მლნ.
43,50 მლნ.
43,50 მლნ.
Interest expense
-289,50 მლნ.
-289,50 მლნ.
-282,00 მლნ.
-282,00 მლნ.
Net interest expenses
-244,50 მლნ.
-244,50 მლნ.
-238,50 მლნ.
-238,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
5,50 მლრდ.
5,50 მლრდ.
6,48 მლრდ.
6,48 მლრდ.
Gain or loss from assets sale
-21,50 მლნ.
-21,50 მლნ.
-2,50 მლნ.
-2,50 მლნ.
AI content may include mistakes. Learn more
Google აპები